SCHEMBL8545139

SCHEMBL8545139

O=C1/C(=C/c2cccc(C(F)(F)F)c2)CCc2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 9/20 0.66
MAOB P27338 2/20 0.65
MAPT P10636 7/20 0.62
PKM P14618 3/20 0.62
KMT2A Q03164 3/20 0.62
MEN1 O00255 2/20 0.62
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
ATM Q13315 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
ALDH1A1 P00352 5/20 0.60
LMNA P02545 5/20 0.60
HPGD P15428 2/20 0.60
CYP19A1 P11511 3/20 0.56
CYP11B2 P19099 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.55
CASP3 P42574 2/20 0.55
SENP8 Q96LD8 2/20 0.55
SENP7 Q9BQF6 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545142 1.00 MIF (0.66) MIFMAOBMAPTPKMKMT2A
SCHEMBL8544214 0.89 MIF (0.64) MIFMAOBMAPTPKMKMT2A
SCHEMBL8544212 0.89 MIF (0.64) MIFMAOBMAPTPKMKMT2A
SCHEMBL8547090 0.86 MAOB (0.72) MIFMAOBMAPTPKMKMT2A
SCHEMBL8547087 0.86 MAOB (0.72) MIFMAOBMAPTPKMKMT2A
SCHEMBL13203410 0.86 MAOB (0.81) MIFMAOBMAPTPKMKMT2A
SCHEMBL8547482 0.84 MAPT (0.72) MIFMAOBMAPTPKMKMT2A
SCHEMBL8547483 0.84 MAPT (0.72) MIFMAOBMAPTPKMKMT2A
SCHEMBL8548081 0.82 MIF (0.71) MIFMAOBMAPTPKMKMT2A
SCHEMBL8548083 0.82 MIF (0.71) MIFMAOBMAPTPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0557075-B1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents LILLY CO ELI (GB) 1998-06-24 EP disclosed
US-5663375-A CELL PROLIFERATION ELI LILLY AND COMPANY (US) 1997-09-02 US disclosed
US-5622987-A PREVENT MIGRATION OR PROLIFERATION OF SMOOTH MUSCLE CELLS ELI LILLY AND COMPANY (US) 1997-04-22 US disclosed
US-5378699-A Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells LILLY INDUSTRIES LIMITED (GB) 1995-01-03 US disclosed
US-5378717-A Therapy for diabetic complications ELI LILLY AND COMPANY (US) 1995-01-03 US disclosed
EP-0557075-A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents LILLY INDUSTRIES LIMITED (GB) 1993-08-25 EP disclosed